Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
12/2003
12/25/2003US20030235531 Method of using metaloporphyrins for treatment of arteriosclerotic lesions
12/25/2003US20030235530 A rhenium-188 isotope radionuclide container comprising an inorganic layer matrix, elution permitting diffusion of rhenium-188 therethrough, ion exchanging
12/24/2003WO2003106659A2 Aptamer-toxin molecules and methods for using same
12/24/2003WO2003106498A2 Agonistic binding molecules to the human ox40 receptor
12/24/2003WO2003105762A2 Treating disease using radium-225
12/24/2003WO2003072558A3 Arylsulfone derivatives
12/24/2003WO2003055917A3 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours
12/24/2003WO2003006491A3 Peptide-based compounds for targeting intergin receptors
12/24/2003WO2003000113A3 Compositions and methods for the diagnosis and treatment of tumor
12/24/2003WO2002046147A3 Perturbed membrane-binding compounds
12/24/2003CA2489469A1 Monoclonal antibody pam4 and its use for diagnosis and therapy of pancreatic cancer
12/24/2003CA2489467A1 Humanized monoclonal antibody hpam4
12/24/2003CA2489004A1 Agonistic binding molecules to the human ox40 receptor
12/24/2003CA2488705A1 A nanoporous particle with a retained target
12/24/2003CA2487809A1 Aptamer-toxin molecules and methods for using same
12/23/2003US6667389 Technetium-99m labeled peptides for imaging
12/23/2003US6667024 Kit comprising molecule with radioisotope binding site linked to antigen-binding fragment of antibody that specifically binds to tumor associated antigen, and metal chelator and basic amino acid or peptide clearing agents
12/23/2003US6666811 Coating microsphere with radioactive, diffusion barrier, and protective layers; solid, multilayered seamless elements are implanted; heating tumors
12/21/2003CA2432777A1 Method of cancer screening primarily utilizing non-invasive cell collection, fluorescence detection techniques, and radio tracing detection techniques
12/20/2003CA2424443A1 Chlorin and bacteriochlorin-based difunctional aminophenyl dtpa and n2s2 conjugates for mr contrast media and radiopharmaceuticals
12/18/2003WO2003104799A2 Imaging method and device for carrying out said method
12/18/2003WO2003104432A2 Anti-cd30 stalk and anti-cd30 antibodies suitable for use in immunotoxins
12/18/2003WO2003104269A1 Synthesis of the peptide cgggqrlgdqwavghlmnh2, labelling method
12/18/2003WO2003104255A2 Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives
12/18/2003WO2003103724A1 Neutrophil imaging in cystic fibrosis
12/18/2003WO2003103723A2 Neutrophil imaging methods in cyctic fibrosis
12/18/2003WO2003103644A2 Guanidino phenylalanin compounds used as urokinase inhibitors
12/18/2003WO2003097052A3 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
12/18/2003WO2002100899A3 Medicament for treating tumours and their metastases using a binding molecule against bone-sialoprotein
12/18/2003WO2002062398A3 Radioactively labelled conjugates of phosphonates
12/18/2003US20030232968 Incubating polyglutamic acid with polyetheyleneimine initiator; for drug screening/delivery
12/18/2003US20030232762 Therapeutic treating breast cancer
12/18/2003US20030232053 Administering to treat rheumatoid arthritis, cancer, restenosis
12/18/2003US20030232017 Cascade polymer bound complexing compounds, their complexes and conjugates, processes for their production, and pharmaceutical agents containing them
12/18/2003US20030232014 Mass spectrometry-based procedure for detection of amino acid modifications, such as phosphorylation; drug discovery
12/18/2003US20030232011 For use in therapy of cancer or an infectious disease
12/18/2003US20030232010 Improved cytotoxic therapy
12/18/2003CA2488753A1 Neutrophil imaging methods in cyctic fibrosis
12/17/2003EP1371365A1 Emulsion/aggregation processes as methods for forming polymeric microspheres characterized by narrow particle size distribution for biomedical human and veterinary administration
12/17/2003EP1370302A1 Dry powder compositions comprising labelled particles for inhalation
12/17/2003EP1370301A2 Actinium-225 complexes and conjugates for targeted radiotherapy
12/17/2003EP1370300A1 Manufacturing process to control particle size
12/17/2003EP1370297A2 Method and composition
12/17/2003EP1370292A1 Use of cd23 antagonists for the treatment of neoplastic disorders
12/17/2003EP1283842B1 Radiopharmaceutical products suitable for the selective labeling of lymphocytes, and their preparation
12/17/2003CN1462276A Peptide-based compounds
12/17/2003CN1131072C Radioactive chitosan complex, its preparation method and use
12/16/2003US6664385 Kidney injury-related molecules
12/16/2003US6664367 Cyclic peptides containing modified disulfide bonds coupled with a chelating agent capable of complexing with diagnostic and therapeutically useful metal ions, antineoplastic agents, enzymes, coenzymes or toxins
12/16/2003US6663866 Radioiodinated residualizing antibody conjugates are stable in vivo and used for radoioimmunodetection and radioimmunotherapy, carbohydrates and peptides
12/16/2003CA2093125C Angiotensin ii antagonists
12/11/2003WO2003102579A2 Method of screening groups of radioactive molecules and applications thereof
12/11/2003WO2003101948A2 Agents for imaging and diagnostic methods using them
12/11/2003WO2003101919A2 Scorpionate-like pendant macrocyclic ligands, complexes and compositions thereof, and methods of using same
12/11/2003WO2003101496A1 Methods and compositions for intravesical therapy of bladder cancer
12/11/2003WO2003101495A1 Methods and compositions for radioimmunotherapy of brain and cns tumors
12/11/2003WO2003101484A1 Compositions and methods for transepithelial molecular transport
12/11/2003WO2003101475A1 Treatment of cell proliferative disorders with chlorotoxin
12/11/2003WO2003101474A1 Combination chemotherapy with chlorotoxin
12/11/2003WO2003101473A1 Suicide tetramers comprising mhc class i and uses thereof
12/11/2003WO2003074568A9 Individualized anti-cancer antibodies
12/11/2003WO2003048306A3 Polycistronic expression of antibodies
12/11/2003WO2003037172A9 Endothelial-cell binding peptides for diagnosis and therapy
12/11/2003WO2003003975A3 Detection and therapy of vulnerable plaque with photodynamic compounds
12/11/2003WO2002087498A8 Diagnostic imaging compositions, their methods of synthesis and use
12/11/2003WO2002057786A3 Compositions and methods for the use of fibronectin fragments in the diagnosis of cancer
12/11/2003US20030229904 Comprises polypeptide for diagnosis, treatment and prevention of tumors
12/11/2003US20030229307 Inflatable member having elastic expansion with limited range
12/11/2003US20030229018 Dimeric TF antagonist
12/11/2003US20030228662 Comprises nucleotide sequences coding tetrodoxin resistant transport protein for diagnosing, prevention and treatment of pain, muscular and cardiac disorders
12/11/2003US20030228647 Composition for monitoring exocrine function and detecting pancreatitis and pancreatic cancer
12/11/2003US20030228305 Compositions and methods for the diagnosis and treatment of tumor
12/11/2003US20030228262 Diagnosis, therapy, image of celluloar disorders; antitumor agents
12/11/2003US20030228260 Drug delivery; central nervous system disorders
12/11/2003US20030228259 Measurement of biosynthesis and breakdown rates of biological molecules that are inaccessible or not easily accessible to direct sampling, non-invasively, by label incorporation into metabolic derivatives and catabolitic products
12/11/2003US20030228258 Suicide tetramers and uses thereof
12/11/2003US20030228257 Induction apoptosis; antiarthritic agents
12/11/2003US20030228256 Suppress lymphocyte response; therapy for autoimmune disease, antidiabetic agents
12/11/2003US20030228255 Radioactive complex; diagnosis, therapy
12/11/2003US20030228254 Contrast agents
12/11/2003CA2494451A1 Treatment of cell proliferative disorders with chlorotoxin
12/11/2003CA2488269A1 Methods and compositions for intravesical therapy of bladder cancer
12/11/2003CA2488219A1 Agents for imaging and diagnostic methods using them
12/11/2003CA2487926A1 Suicide tetramers comprising mhc class i and uses thereof
12/11/2003CA2487692A1 Methods and compositions for radioimmunotherapy of brain and cns tumors
12/11/2003CA2487425A1 Combination chemotherapy with chlorotoxin
12/11/2003CA2486911A1 Method of screening groups of radioactive molecules and applications thereof
12/10/2003EP1368064A2 Tetradentate peptide-chelate conjugates for colorectal cancer diagnosis
12/10/2003CN1461344A Multivalent target binding protein
12/10/2003CN1461217A Novel uses of non-peptide bombesin receptor antagonists for treating anxiety and panic disorders
12/10/2003CN1460522A Egg yolk antibody composite for preventing and curing diseases and its preparaion method
12/09/2003US6662040 Methods of photoacoustic imaging
12/09/2003US6660530 Methods for labeling β-amyloid plaques and neurofibrillary tangles
12/09/2003US6660247 Multiple stimulus reversible hydrogels
12/09/2003US6660246 Ligands and metal complexes thereof
12/09/2003CA2261772C Process and apparatus for the production of bi-212 and a use thereof
12/04/2003WO2003100033A2 ANTI-αvβ6 ANTIBODIES
12/04/2003WO2003099810A2 Radiopharmaceuticals for imaging infection and inflammation
12/04/2003WO2003099347A1 Cell delivery fluid for prevention of cell settling in delivery system
12/04/2003WO2003099342A1 Labeled adenosine for use in positron emission tomography
1 ... 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 ... 243